<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04013308</url>
  </required_header>
  <id_info>
    <org_study_id>URzeszow scientific circle</org_study_id>
    <nct_id>NCT04013308</nct_id>
  </id_info>
  <brief_title>Iontophoresis With Potassium Iodide and Thyroid Function</brief_title>
  <official_title>Iontophoresis With Potassium Iodide and the Level of Thyroid Hormones in Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rzeszow</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Rzeszow</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study: To assess the influence of iontophoresis treatment with 2% potassium
      iodide on the level of thyroid hormones (TSH, FT3, FT4) The study group: conducting 10
      iontophoresis treatments with Potassium iodide; The control group: conducting 10 placebo
      treatments with iontophoresis with destilled water; Intervention: 10 iontophoresis treatments
      with 2% potassium iodide in healthy individuals.

      Test the level of thyroid hormones before and after the 10 iontophoresis treatments; The
      study allows to assess the influence of iodine on the function of thuroid gland.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 27, 2019</start_date>
  <completion_date type="Actual">July 31, 2019</completion_date>
  <primary_completion_date type="Actual">July 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the level of thyroid gland hormones (TSH, FT3, FT4)</measure>
    <time_frame>change in the thyroid hormones level from the baseline to 14 days after the last treatment</time_frame>
    <description>to test thyroid hormones before and after 10 iontophoresis treatments</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">56</enrollment>
  <condition>Thyroid Dysfunction</condition>
  <arm_group>
    <arm_group_label>10 iontophoresis treatments with potassium iodide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>10 iontophoresis treatments with placebo</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Iontophoresis with 2% potassium iodide</intervention_name>
    <description>10 iontophoresis treatments with 2% potassium iodide on the area of thyroid gland; electrodes with tin foil (Amperage:2mA, duration: 30min)</description>
    <arm_group_label>10 iontophoresis treatments with potassium iodide</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy individuals with normal thyroid function

        Exclusion Criteria:

          -  individuals with thyroid disorders,

          -  taking thyroid medication,

          -  using drugs, alcohol, cigaretttes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>23 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre for Innovative Research in Medical and Natural Sciences' Medical Faculty of University of Rzeszow</name>
      <address>
        <city>Rzeszów</city>
        <state>Podkarpackie</state>
        <zip>35-310</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>July 3, 2019</study_first_submitted>
  <study_first_submitted_qc>July 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 9, 2019</study_first_posted>
  <last_update_submitted>August 14, 2019</last_update_submitted>
  <last_update_submitted_qc>August 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rzeszow</investigator_affiliation>
    <investigator_full_name>Jolanta Zwolińska</investigator_full_name>
    <investigator_title>Head of the Laboratory of Physical Factors</investigator_title>
  </responsible_party>
  <keyword>Iontophoresis</keyword>
  <keyword>potassium iodine</keyword>
  <keyword>thyroid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

